Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

BACKGROUND: Eosinophilic granulomatosis with polyangiitis is an eosinophilic vasculitis. Mepolizumab, an anti–interleukin-5 monoclonal antibody, reduces blood eosinophil counts and may have value in the treatment of eosinophilic granulomatosis with polyangiitis. METHODS: In this multicenter, double-...

詳細記述

保存先:
書誌詳細
出版年:N Engl J Med
主要な著者: Wechsler, M.E., Akuthota, P., Jayne, D., Khoury, P., Klion, A., Langford, C.A., Merkel, P.A., Moosig, F., Specks, U., Cid, M.C., Luqmani, R., Brown, J., Mallett, S., Philipson, R., Yancey, S.W., Steinfeld, J., Weller, P.F., Gleich, G.J.
フォーマット: Artigo
言語:Inglês
出版事項: 2017
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5548295/
https://ncbi.nlm.nih.gov/pubmed/28514601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1702079
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料